# A Study to Assess the Effect of Itraconazole, Phenytoin and Gemfibrozil on the Drug Levels of BMS-986166 in Healthy Participants

> **NCT04956627** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 15 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** BMS-986166
- **DRUG:** Itraconazole
- **DRUG:** Extended Phenytoin Sodium
- **DRUG:** Gemfibrozil

## Key facts

- **NCT ID:** NCT04956627
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-28
- **Primary completion:** 2022-04-27
- **Final completion:** 2022-04-27
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2022-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04956627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04956627, "A Study to Assess the Effect of Itraconazole, Phenytoin and Gemfibrozil on the Drug Levels of BMS-986166 in Healthy Participants". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04956627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*